Kimberly J Van Zee

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit
    Katrina H Moore
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, MRI 1026, New York, NY 10021, USA
    Ann Surg Oncol 14:2911-7. 2007
  2. ncbi A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy
    Kimberly J Van Zee
    Departments of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 10:1140-51. 2003
  3. ncbi Breast imaging: a breast surgeon's perspective
    Kimberly J Van Zee
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Radiol Clin North Am 40:517-20. 2002
  4. ncbi Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements
    Sarah A McLaughlin
    Breast Service, Department of Surgery, Behavioral Science Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 26:5213-9. 2008
  5. ncbi The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy
    Udo Rudloff
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 251:583-91. 2010
  6. ncbi A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer
    Tari A King
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 11:535-41. 2004
  7. ncbi Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma
    Elisa Rush Port
    Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 195:167-72. 2002
  8. ncbi Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women
    Larissa K F Temple
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 9:654-62. 2002
  9. ncbi Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ
    Udo Rudloff
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 28:3762-9. 2010
  10. ncbi Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer
    Matthew S Pugliese
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 17:1063-8. 2010

Collaborators

Detail Information

Publications48

  1. ncbi Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit
    Katrina H Moore
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, MRI 1026, New York, NY 10021, USA
    Ann Surg Oncol 14:2911-7. 2007
    ..Although it is well established that nodal status for invasive disease is prognostically important, the clinical relevance of a positive SLN in patients with DCIS remains undetermined...
  2. ncbi A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy
    Kimberly J Van Zee
    Departments of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 10:1140-51. 2003
    ..Accurate estimates of the likelihood of additional disease in the axilla could assist greatly in decision-making regarding further treatment...
  3. ncbi Breast imaging: a breast surgeon's perspective
    Kimberly J Van Zee
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Radiol Clin North Am 40:517-20. 2002
    ..They have also facilitated a closer working relationship between breast imager and surgeon and have contributed greatly to the surgeon's ability to optimally diagnose and treat breast cancer...
  4. ncbi Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements
    Sarah A McLaughlin
    Breast Service, Department of Surgery, Behavioral Science Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 26:5213-9. 2008
    ..The aim of this study was to determine the long-term prevalence of lymphedema after SLN biopsy (SLNB) alone and after SLNB followed by axillary lymph node dissection (SLNB/ALND)...
  5. ncbi The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy
    Udo Rudloff
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 251:583-91. 2010
    ..There remains variation in the use of radiation therapy (RT) in women with ductal carcinoma in situ (DCIS), despite prospective randomized trials documenting its benefit in reducing the risk of ipsilateral breast tumor recurrence (IBTR)...
  6. ncbi A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer
    Tari A King
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 11:535-41. 2004
    ..This study examined whether the volume of isosulfan blue dye used in sentinel lymph node (SLN) mapping in breast cancer is related to the SLN identification rate or to the incidence of allergic reactions...
  7. ncbi Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma
    Elisa Rush Port
    Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 195:167-72. 2002
    ..Further study is required to better define the subset of patients in whom reoperative SLN biopsy can replace ALND...
  8. ncbi Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women
    Larissa K F Temple
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 9:654-62. 2002
    ..Sensory morbidity improves in the first 3 months after surgery, but patients continue to report sensory morbidity at 1 year. Longitudinal follow-up is required to further assess lymphedema...
  9. ncbi Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ
    Udo Rudloff
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 28:3762-9. 2010
    ..However, they have never been proven to improve survival, and in themselves carry rare but serious risks. Individualized estimation of IBTR risk would assist in decision making regarding the various treatment options for women with DCIS...
  10. ncbi Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer
    Matthew S Pugliese
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 17:1063-8. 2010
    ..The goal of this study was to examine factors associated with ALND in IHC-only patients...
  11. ncbi Axillary node staging for microinvasive breast cancer: is it justified?
    John M Lyons
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:3416-21. 2012
    ..The natural history and role of axillary staging in microinvasive breast cancer (DCISM) remains controversial. We report clinical characteristics and outcome in patients with DCISM, focusing on the role of sentinel lymph node (SLN) biopsy...
  12. ncbi Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation
    José Luiz B Bevilacqua
    Department of Surgery, Memorial Sloan Kettering Cancer Center, MRI 1026, New York, NY 10021, USA
    J Clin Oncol 25:3670-9. 2007
    ..We developed a user-friendly prediction model (nomogram) based on a large data set to assist in predicting the presence of SLN metastasis...
  13. ncbi Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema
    Jessica I Goldberg
    Breast Service, Department of Surgery, Evelyn H Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 18:2866-72. 2011
    ..In this analysis, we examined the relationship between number of LNs excised during SLNB and patient-perceived lymphedema...
  14. ncbi A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram
    Julia Park
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 245:462-8. 2007
    ....
  15. ncbi Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection
    Roberta H Baron
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Ann Surg Oncol 14:1653-61. 2007
    ....
  16. ncbi Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection
    Roberta H Baron
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Oncol Nurs Forum 31:691-8. 2004
    ....
  17. ncbi Sentinel lymph node drainage in multicentric breast cancers
    Hong Jin Kim
    Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Breast J 8:356-61. 2002
    ..However, further studies are needed to validate the accuracy of SLN biopsy in multicentric breast cancers...
  18. ncbi Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema
    Jessica I Goldberg
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 17:3278-86. 2010
    ..We hypothesized that a higher number of lymph nodes (LNs) removed during SLNB is associated with a higher risk of lymphedema...
  19. ncbi Tissue expander breast reconstruction is not associated with an increased risk of lymphedema
    Tomer Avraham
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 17:2926-32. 2010
    ..Therefore, the purpose of this study was to determine the impact of immediate tissue expander breast reconstruction on the risk of developing lymphedema...
  20. ncbi Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up
    Christine A Wynveen
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Am J Surg Pathol 35:1-14. 2011
    ..This type of tumor is strongly estrogen receptor positive and hormonal therapy should be pursued for its management, whereas the benefit of radiation after lumpectomy remains unclear...
  21. ncbi A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy
    Michael W Kattan
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 101:2509-15. 2004
    ....
  22. ncbi Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy
    Udo Rudloff
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 115:1203-14. 2009
    ....
  23. ncbi Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease
    Shicha Kumar
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 17:2909-19. 2010
    ....
  24. ncbi Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors
    Sarah A McLaughlin
    Breast Service, Department of Surgery, Behavioral Science Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 26:5220-6. 2008
    ..This study was undertaken to examine patient perceptions of lymphedema and use of precautionary behaviors several years after axillary surgery...
  25. ncbi The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers
    Eleni Tousimis
    Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 197:529-35. 2003
    ..Our retrospective data suggest SLNB may be used as a reliable alternative to conventional ALND in selected patients with MC or MF disease. Further studies in this patient population are warranted...
  26. ncbi Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction
    Lawrence Koutcher
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, NY 10065, USA
    Radiother Oncol 94:319-23. 2010
    ..To evaluate radiation plans of patients undergoing mastectomy with immediate expander-implant reconstruction followed by postmastectomy radiation therapy (PMRT)...
  27. ncbi Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection
    Roberta H Baron
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Oncol Nurs Forum 29:651-9. 2002
    ....
  28. ncbi Perpendicular inked versus tangential shaved margins in breast-conserving surgery: does the method matter?
    Mary Jo Wright
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 204:541-9. 2007
    ..The purpose of this study was to compare the incidence of positive margins and rates of reexcision between two methods of margin assessment at a single institution...
  29. ncbi Utility of breast magnetic resonance imaging in patients with occult primary breast cancer
    Claire L Buchanan
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 12:1045-53. 2005
    ..CONCLUSIONS: Breast MRI detects mammographically occult cancer in half of women with axillary metastases, regardless of breast density. MRI is a powerful tool for stage II and stage IV patients with occult primary breast cancer...
  30. ncbi Is there a low-grade precursor pathway in breast cancer?
    Tari A King
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA
    Ann Surg Oncol 19:1115-21. 2012
    ..Our objective was to examine the relationship between histologic grade and molecular subtype in women with lobular carcinoma in situ (LCIS) and ductal carcinoma in situ (DCIS) who developed subsequent ipsilateral invasive breast cancers...
  31. ncbi Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram
    Michelle C Specht
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, MRI 1026, New York, New York 10021, USA
    Ann Surg Oncol 12:654-9. 2005
    ..It seems that most clinicians can improve their predictive ability by using the nomogram to predict the likelihood of additional non-SLN metastases in a woman with a positive SLN biopsy result...
  32. ncbi MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer
    Laura Liberman
    Breast Imaging Section, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    AJR Am J Roentgenol 180:333-41. 2003
    ..Cancer was found in 20% of women who underwent contralateral breast biopsy and in 5% of women who underwent contralateral breast MR imaging...
  33. ncbi Minimally invasive breast surgery
    Julie Kepple
    Department of Surgery, Division of Breast Surgical Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    J Am Coll Surg 199:961-75. 2004
  34. ncbi Long-term outcomes in breast cancer patients undergoing immediate 2-stage expander/implant reconstruction and postmastectomy radiation
    Alice Ho
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 118:2552-9. 2012
    ..The long-term rates of permanent implant removal or replacement (PIRR) and clinical outcomes in patients treated with a uniform reconstructive surgery and radiation regimen were evaluated...
  35. ncbi Point: sentinel lymph node biopsy is indicated for patients with DCIS
    Hiram S Cody
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Natl Compr Canc Netw 1:199-206. 2003
    ..In DCIS, SLN biopsy may ultimately prove to be a more sensitive screening test for occult invasion than examination of the breast itself...
  36. ncbi Fast MRI-guided vacuum-assisted breast biopsy: initial experience
    Laura Liberman
    Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 181:1283-93. 2003
    ..MRI-guided biopsy was performed with a vacuum-assisted probe, followed by placement of a localizing clip, and then needle localization for surgical excision. Vacuum-assisted biopsy and surgical histology were correlated...
  37. ncbi Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter?
    Heather B Neuman
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer 116:1226-33. 2010
    ..The objective of the current study was to identify subsets of patients who may benefit from primary tumor treatment and assess the frequency of local disease progression...
  38. ncbi Papilloma diagnosed at MRI-guided vacuum-assisted breast biopsy: is surgical excision still warranted?
    Sandra B Brennan
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 199:W512-9. 2012
    ..The objective of our study was to determine the frequency of cancer at surgery in breast lesions yielding papilloma at MRI-guided 9-gauge vacuum-assisted biopsy (VAB) and to determine whether any features are associated with cancer upgrade...
  39. ncbi A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men
    Anne S Reiner
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
    Breast Cancer Res Treat 130:301-6. 2011
    ..Lymphedema is a common complication affecting men with breast cancer as well as women and appropriate treatment and rehabilitation strategies need to be implemented for both genders...
  40. ncbi Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II-III breast cancer: treatment intervals and clinical outcomes
    Jean L Wright
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 70:43-50. 2008
    ....
  41. ncbi Desmoid tumors (fibromatoses) of the breast: a 25-year experience
    Heather B Neuman
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
    Ann Surg Oncol 15:274-80. 2008
    ..Breast desmoid tumors are rare and often clinically mistaken for carcinoma. We reviewed our 25-year institutional experience with breast desmoid tumors...
  42. ncbi Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast
    Andrea V Barrio
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, MRI 1026, New York, New York 10021, USA
    Ann Surg Oncol 14:2961-70. 2007
    ..Phyllodes tumors (PT) are rare fibroepithelial neoplasms of the breast with unpredictable behavior. We reviewed our single institution experience with PT over 51 years to identify factors predictive of local recurrence (LR) and metastasis...
  43. ncbi Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer
    Leslie L Montgomery
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Anesth Analg 95:385-8, table of contents. 2002
    ..Bronchospasm and respiratory compromise are unusual, and most patients can be treated with short-term pressor support. Patients with a sulfa allergy do not display a cross-sensitivity to isosulfan blue dye...
  44. ncbi Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?
    Daniel X Choi
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:1302-10. 2013
    ..This study reports subsequent ipsilateral breast events (IBE) in patients with borderline lesions compared with those with DCIS...
  45. ncbi A safety and efficacy pilot study of acupuncture for the treatment of chronic lymphoedema
    Barrie R Cassileth
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1429 First Avenue, New York, NY 10021, USA
    Acupunct Med 29:170-2. 2011
    ..Needling and even lifting of objects using the affected arm has been prohibited, but our clinical experience and that of others suggested that acupuncture was safe and that it might be a useful treatment for lymphoedema...
  46. ncbi One operation after percutaneous diagnosis of nonpalpable breast cancer: frequency and associated factors
    Laura Liberman
    Department of Radiology, Breast Imaging Section, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 178:673-9. 2002
    ..5% of women who had mastectomy. Among women who had breast conservation, one operation was significantly more likely if histologic underestimation was absent or if a mammographic mass was present...
  47. ncbi A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy
    Matthew G Fury
    Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021-6007, USA
    Cancer J 11:241-7. 2005
    ..8 months for sites below the clavicle. DISCUSSION: Angiosarcoma is an aggressive malignancy characterized by biologic heterogeneity at different anatomic sites and relative sensitivity to paclitaxel and doxorubicin...
  48. ncbi Validating a predictive model for presence of additional disease in the non-sentinel lymph nodes of a woman with sentinel node positive breast cancer
    Kimberly J Van Zee
    Ann Surg Oncol 14:2177-8. 2007